Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 66

1.

Frequency of dosing and comparative doses of mometasone furoate: a meta-analysis.

Hart K, Weatherall M, Shirtcliffe P, Beasley R.

Respirology. 2009 Nov;14(8):1166-72. doi: 10.1111/j.1440-1843.2009.01632.x. Epub 2009 Oct 8. Review.

PMID:
19818054
2.

Efficacy and safety of mometasone furoate administered once-daily in the evening in patients with persistent asthma dependent on inhaled corticosteroids.

D'Urzo A, Karpel JP, Busse WW, Boulet LP, Monahan ME, Lutsky B, Staudinger H.

Curr Med Res Opin. 2005 Aug;21(8):1281-9.

PMID:
16083538
3.

Mometasone furoate dry powder inhaler: a once-daily inhaled corticosteroid for the treatment of persistent asthma.

Karpel JP, Nelson H.

Curr Med Res Opin. 2007 Nov;23(11):2897-911. Review.

PMID:
17922978
4.

Mometasone furoate administered once daily is as effective as twice-daily administration for treatment of mild-to-moderate persistent asthma.

Kemp JP, Berkowitz RB, Miller SD, Murray JJ, Nolop K, Harrison JE.

J Allergy Clin Immunol. 2000 Sep;106(3):485-92.

PMID:
10984368
5.

Comparison of once-daily to twice-daily treatment with mometasone furoate dry powder inhaler.

Noonan M, Karpel JP, Bensch GW, Ramsdell JW, Webb DR, Nolop KB, Lutsky BN.

Ann Allergy Asthma Immunol. 2001 Jan;86(1):36-43.

PMID:
11206236
6.

A randomized controlled trial of mometasone furoate nasal spray for the treatment of nasal polyposis.

Stjärne P, Mösges R, Jorissen M, Passàli D, Bellussi L, Staudinger H, Danzig M.

Arch Otolaryngol Head Neck Surg. 2006 Feb;132(2):179-85.

PMID:
16490876
7.

Effects of mometasone furoate given once daily in the evening on lung function and symptom control in persistent asthma.

Karpel JP, Busse WW, Noonan MJ, Monahan ME, Lutsky B, Staudinger H.

Ann Pharmacother. 2005 Dec;39(12):1977-83. Epub 2005 Nov 1.

PMID:
16264062
8.

Mometasone furoate antagonizes AMP-induced bronchoconstriction in patients with mild asthma.

Holgate ST, Arshad H, Stryszak P, Harrison JE.

J Allergy Clin Immunol. 2000 May;105(5):906-11.

PMID:
10808170
9.

Comparable morning versus evening administration of once-daily mometasone furoate dry powder inhaler.

Zetterström O, Dahl R, Lindqvist A, Olsson P.

Respir Med. 2008 Oct;102(10):1406-11. doi: 10.1016/j.rmed.2008.04.024. Epub 2008 Jul 21.

10.

Comparison of once-daily mometasone furoate versus once-daily budesonide in patients with moderate persistent asthma.

Corren J, Berkowitz R, Murray JJ, Prenner B.

Int J Clin Pract. 2003 Sep;57(7):567-72. Erratum in: Int J Clin Pract. 2007 Feb;61(2):352. Dosage error in article text.

PMID:
14529054
11.

Use of mometasone furoate administered via a dry powder inhaler in the treatment of asthma.

Zeidler M, Corren J, Tashkin DP.

Curr Med Res Opin. 2010 Jun;26(6):1295-305. doi: 10.1185/03007991003701152. Review.

PMID:
20370376
12.

Evaluation of efficacy and safety of budesonide delivered via two dry powder inhalers.

Kerwin EM, Pearlman DS, de Guia T, Carlsson LG, Gillen M, Uryniak T, Simonson SG.

Curr Med Res Opin. 2008 May;24(5):1497-510. doi: 10.1185/030079908X297240 . Epub 2008 Apr 16.

PMID:
18419878
14.

Fluticasone given once versus twice a day: meta-analysis.

Masoli M, Weatherall M, Beasley R.

Respirology. 2005 Mar;10(2):183-8.

PMID:
15823183
15.

Inhaled mometasone furoate improves health-related quality of life in patients with persistent asthma.

Karpel J, D'urzo A, Lockey RF.

J Asthma. 2008 Nov;45(9):747-53. doi: 10.1080/02770900802220611. Review.

PMID:
18972289
16.
17.

Inhaled mometasone furoate reduces oral prednisone requirements while improving respiratory function and health-related quality of life in patients with severe persistent asthma.

Fish JE, Karpel JP, Craig TJ, Bensch GW, Noonan M, Webb DR, Silverman B, Schenkel EJ, Rooklin AR, Ramsdell JW, Nathan R, Leflein JG, Grossman J, Graft DF, Gower RG, Garay SM, Frigas E, Degraff AC, Bronsky EA, Bernstein DI, Berger W, Shneyer L, Nolop KB, Harrison JE.

J Allergy Clin Immunol. 2000 Nov;106(5):852-60.

PMID:
11080706
18.

Inhaled mometasone furoate reduces oral prednisone usage and improves lung function in severe persistent asthma.

Karpel JP, Nayak A, Lumry W, Craig TJ, Kerwin E, Fish JE, Lutsky B.

Respir Med. 2007 Mar;101(3):628-37. Epub 2006 Jul 26.

20.

Dose-ranging study of a new steroid for asthma: mometasone furoate dry powder inhaler.

Bernstein DI, Berkowitz RB, Chervinsky P, Dvorin DJ, Finn AF, Gross GN, Karetzky M, Kemp JP, Laforce C, Lumry W, Mendelson LM, Nelson H, Pearlman D, Rachelefsky G, Ratner P, Repsher L, Segal AT, Selner JC, Settipane GA, Wanderer A, Cuss FM, Nolop KB, Harrison JE.

Respir Med. 1999 Sep;93(9):603-12.

PMID:
10542973

Supplemental Content

Support Center